InterMedical Care and Lab Hospital PCL (BKK:IMH-R) 10-Year Sharpe Ratio: N/A (As of Sep. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:IMH-R InterMedical Care and Lab Hospital PCL BKK:IMH-R
70 GF Score
Price ฿3.62
GF Value ฿5.85
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is InterMedical Care and Lab Hospital PCL 10-Year Sharpe Ratio?

The 10-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past ten years. As of today (2026-09-06), InterMedical Care and Lab Hospital PCL's 10-Year Sharpe Ratio is Not available.


InterMedical Care and Lab Hospital PCL  (BKK:IMH-R) 10-Year Sharpe Ratio Explanation

The 10-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past ten years. It is calculated as the annualized result of the average ten-year monthly excess returns divided by its standard deviation in the ten-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


InterMedical Care and Lab Hospital PCL 10-Year Sharpe Ratio Related Terms


BKK:IMH-R vs HCA, THC, EHC: 10-Year Sharpe Ratio Comparison

For the Medical Care Facilities subindustry, InterMedical Care and Lab Hospital PCL's 10-Year Sharpe Ratio, along with its competitors' market caps and 10-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InterMedical Care and Lab Hospital PCL 10-Year Sharpe Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InterMedical Care and Lab Hospital PCL's 10-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where InterMedical Care and Lab Hospital PCL's 10-Year Sharpe Ratio falls into.


BKK:IMH-R
70GF Score
InterMedical Care and Lab Hospital PCL BKK:IMH-R
10-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InterMedical Care and Lab Hospital PCL 10-Year Sharpe Ratio Calculation

The 10-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last ten years. A stock / portfolio's 10-Year Sharpe Ratio can be calculated by dividing the difference between the ten-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past ten years.

Is InterMedical Care and Lab Hospital PCL (BKK:IMH-R) Overvalued in 2026?

Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL stock appears to be undervalued. The current stock price of ฿3.62 is trading 38.1% below its estimated GF Value™ of ฿5.85. GuruFocus considers InterMedical Care and Lab Hospital PCL to be Possible Value Trap.

Key valuation signals for BKK:IMH-R:

  • 10-Year Sharpe Ratio: N/A
  • GF Value™: ฿5.85 vs. price of ฿3.62 (38.1% below fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the BKK:IMH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


InterMedical Care and Lab Hospital PCL Business Description

Other Exchanges IMH:Thailand
Address 442 Bang Waek Road, Bang Waek Sub-district, Pha-si-cha-roen District, Bangkok, THA, 10160
InterMedical Care and Lab Hospital PCL is a company principally engaged in specialty medical hospitals, and occupational medicine. The business segments of the firm are Prachapat hospital, Occupational Medicine hospital and Environmental Analysis. Prachapat Hospital is engaged in rendering medical services to patients under government welfare schemes. Occupational Medicine Hospital is engaged in providing physical examination services. Majority of revenue is from Hospital Segment. Geographically, the company operates in Thailand.
70GF Score

Get the complete analysis for BKK:IMH-R

10-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿3.62
Price
฿5.85
GF Value